---
title: "GlobalFoundries falls 7%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306308286.md"
description: "GlobalFoundries fell 7.29% to US$36.10. Down 12.96% over five sessions and down 48.81% over six months."
datetime: "2026-11-20T17:04:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306308286.md)
  - [en](https://longbridge.com/en/news/306308286.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306308286.md)
generator: "portal-rs"
---

# GlobalFoundries falls 7%

GlobalFoundries (GFS.US) fell more than **7%** during regular trading to **$36.10**.

The stock is down 12.96% over the past five sessions and down 48.81% over the past six months. It sits 60.84% below its 52-week high of US$92.18.

The Nasdaq Composite is down 8.36% over the past five sessions and down 0.89% year to date.

The semiconductors industry index fell 9.2% over the same period.

The company reported a third-quarter net loss of $271 million on revenue of $1.899 billion. It guided to fourth-quarter revenue of about $2 billion and diluted earnings per share of approximately $0.47.

Needham lowered its price target on the stock to $55 from $80, while Wedbush cut its target to $45 from $72 and assigned a Neutral rating.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [GFS.US](https://longbridge.com/en/quote/GFS.US.md)

## Related News & Research

- [GLOBALFOUNDRIES Stock After Earnings Loss Guidance And Dividend Affirmation](https://longbridge.com/en/news/305212406.md)
- [GFS Stock in Focus as Japan, US Discuss Up to $19 Billion Chip Plant Under Tariff Investment Pact: Report](https://longbridge.com/en/news/299299337.md)
- [Snowflake (SNOW) Gains AI Tie Up, Is The Stock Too Expensive?](https://longbridge.com/en/news/306344244.md)
- [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md)
- [T Mobile US (TMUS) Rolls Out AI AutoPilot Across 5G Network Nationwide](https://longbridge.com/en/news/306343882.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**